Croda International Plc Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Croda International Plc Stock Forecast and Price Target
The average price target for Croda International Plc's stock of £51.00 recently provided by six leading analysts would represent a 5.57% upside from its last closing price if reached. This potential increase is based on a high estimate of £57.00 and a low estimate of £41.00. If you are interested in CRDA stock, it is important to also consider its competitors.
5.57% Upside
Croda International Plc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Croda International Plc has seen a decline in its Price, from £51.07 to £0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach £53.11 – an increase of 100.00%. For the next seven years, experts predict that Croda International Plc's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XOM Stock Forecast | Exxon Mobil Corp | Outperform |
4
|
$116.17 | Buy/Sell | $124.27 | 13.20% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$148.72 | Buy/Sell | $174.55 | 14.31% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$130.38 | Buy/Sell | $130.51 | 9.68% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£121.18 | Buy/Sell | £165.99 | 34.47% |
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF89.78 | Buy/Sell | CHF105.00 | 19.87% |
Croda International Plc Revenue Forecast for 2023 - 2025 - 2030
Croda International Plc's Revenue has grown In the last three years, rising from £1.39B to £1.69B – a growth of 21.88%. In the next year, analysts believe that Revenue will reach £1.79B – an increase of 5.45%. For the next seven years, experts predict that Croda International Plc's Revenue will grow at a rate of 56.36%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF221.30 | Buy/Sell | CHF307.83 | 23.14% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$300.30 | Buy/Sell | $303.65 | 6.56% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$27.77 | Buy/Sell | $32.87 | 9.83% |
.jpg)
Croda International Plc Dividend per Share Forecast for 2023 - 2025 - 2030
Croda International Plc's Dividend per Share has seen impressive growth In the last three years, rising from £0.91 to £1.09 – a growth of 19.78%. In the next year, analysts believe that Dividend per Share will reach £1.13 – an increase of 3.67%. For the next seven years, the forecast is for Dividend per Share to grow by 13.95%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$410.24 | Buy/Sell | $457.59 | 11.21% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.04 | Buy/Sell | $58.15 | 22.62% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£17.61 | Buy/Sell | £17.30 | 10.73% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$65.46 | Buy/Sell | $87.82 | 22.21% |
| SHW Stock Forecast | Sherwin Williams | Outperform |
15
|
$318.75 | Buy/Sell | $317.38 | 7.92% |
| 4063 Stock Forecast | Shin-Etsu Chemical | Outperform |
4
|
¥5.90k | Buy/Sell | ¥5.13k | 21.97% |
Croda International Plc EBITDA Forecast for 2023 - 2025 - 2030
Croda International Plc's EBITDA has decreased In the last three years, from £369.70M to £323.30M – a 12.55% drop. In the next year, analysts predict that EBITDA will jump to £444.24M – up 37.41% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 159.51%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ECL Stock Forecast | Ecolab | Hold |
18
|
$232.92 | Buy/Sell | $205.36 | 3.04% |
| BAS Stock Forecast | BASF | Outperform |
12
|
50.08€ | Buy/Sell | 49.50€ | 11.82% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF520.20 | Buy/Sell | CHF516.89 | 14.38% |
Croda International Plc EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Croda International Plc's EBIT has seen a drop from £300.50M to £252.90M – a 15.84% decrease. Analysts predict that Croda International Plc's EBIT will increase in the upcoming year, reaching £352.02M. This would represent an increase of 39.19%. Over the next seven years, experts predict that Croda International Plc's EBIT will grow at a rate of 184.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF4.07k | Buy/Sell | CHF3.14k | -5.45% |
| LYB Stock Forecast | LyondellBasell Industries NV | Hold |
14
|
$101.45 | Buy/Sell | $103.00 | 4.48% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$218.92 | Buy/Sell | $299.62 | 31.78% |
Croda International Plc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Croda International Plc has seen a decline in its EPS, from £1.75 to £0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach £1.82 – an increase of 100.00%. For the next seven years, experts predict that Croda International Plc's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PPG Stock Forecast | PPG Industries | Outperform |
13
|
$134.21 | Buy/Sell | $159.04 | 16.24% |
| DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
105.95€ | Buy/Sell | 114.60€ | 13.26% |
| NZYM B Stock Forecast | Novozymes A/S | Outperform |
18
|
kr414.20 | Buy/Sell | kr365.54 | 8.64% |
Site Navigation
.jpg)